文献速递肝病

ALT是肥胖和超重儿童晚期代谢功能障碍相关脂肪性肝病的有效筛查工具

ALT Is an Effective Screening Tool for Advanced Metabolic Dysfunction-Associated Steatotic Liver Disease in Children With Obesity and Overweight.
PubMed 文献 · Clin Gastroenterol Hepatol · 2025-06-13

本研究纳入322名8-18岁肥胖或超重且至少有一项MASLD危险因素的儿童,按ALT水平分组评估以ALT为基础的筛查算法对显著纤维化风险(VCTE≥7.4 kPa)的检测效果。结果显示VCTE≥7.4 kPa的患病率随ALT升高而显著增加,其他无创检查在本队列中未表现出更优性能。结论认为ALT是肥胖或超重且伴有额外危险因素儿童肝脏硬度增加的有效初筛步骤。

要点

  • 在322名肥胖或超重儿童中,VCTE≥7.4 kPa的患病率随ALT升高而显著增加(P < .001)。
  • ALT≥80 IU/L与VCTE≥7.4 kPa正相关(OR 2.91,95%CI 1.25-6.74)。
  • 其他无创检查在本队列中对VCTE≥7.4 kPa的诊断性能未优于ALT。

核心结论

  • ALT是肥胖或超重且伴有额外危险因素儿童肝脏硬度增加(提示显著纤维化)的有效初筛步骤。

研究设计与样本

  • 纳入8-18岁、肥胖或超重且至少有一项MASLD额外危险因素的儿童322名(64%为男性,中位年龄13岁,平均BMI z评分3.5)。
  • 参与者接受ALT筛查并按ALT水平分为4组,同时进行振动控制瞬时弹性成像(VCTE)并以≥7.4 kPa为阈值分析。
  • 采用logistic回归分析评估与VCTE≥7.4 kPa相关的患者特征,并将ALT的诊断准确性与其它无创检查进行比较。

主要发现

  • VCTE≥7.4 kPa的患病率随ALT升高而显著增加:ALT正常组为1.9%,轻度ALT升高组(≥正常值上限[ULN]:女性22 IU/L,男性26 IU/L)为16.4%,中度ALT升高组(≥2倍ULN:女性44-79 IU/L,男性52-79 IU/L)为21.3%,显著ALT升高组(≥80 IU/L)为38.9%(P < .001)。
  • VCTE≥7.4 kPa与ALT≥80 IU/L正相关(OR 2.91,95%CI 1.25-6.74)。
  • VCTE≥7.4 kPa与年龄正相关(OR 1.50,95%CI 1.27-1.76)。
  • VCTE≥7.4 kPa与男性正相关(OR 2.37,95%CI 1.04-5.40)。
  • VCTE≥7.4 kPa与BMI z评分正相关(OR 3.01,95%CI 1.62-5.61),与HOMA-IR正相关(OR 1.10,95%CI 1.00-1.13)。

关键数值与推荐

  • ALT正常定义为低于正常值上限(女性22 IU/L,男性26 IU/L)。
  • 轻度ALT升高定义为≥正常值上限(女性22 IU/L,男性26 IU/L)。
  • 中度ALT升高定义为≥2倍正常值上限(女性44-79 IU/L,男性52-79 IU/L)。
  • 显著ALT升高定义为≥80 IU/L。
  • VCTE分析阈值为≥7.4 kPa。

临床怎么用

  • 原文结论认为ALT是肥胖或超重且伴有额外危险因素儿童肝脏硬度增加的有效初筛步骤。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Metabolic dysfunction-associated steatotic liver disease (MASLD) is common in children with obesity and overweight. However, neither the optimal method nor risks and benefits of screening have been established. This study aims to evaluate the effectiveness of an alanine aminotransferase (ALT)-based screening algorithm for detecting those at risk of significant fibrosis. METHODS: Children (aged 8-18 years) with (1) obesity or (2) overweight and ≥1 additional risk factor for MASLD were included. Participants were screened for MASLD using ALT and analyzed in 4 groups based on ALT levels. Vibration-controlled transient elastography (VCTE) was performed and analyzed at a threshold of ≥7.4 kPa. Patient features associated with VCTE ≥7.4 kPa were assessed using logistic regression analysis. Diagnostic accuracy of ALT was compared with other noninvasive tests. RESULTS: Among 322 children (64% male; median age, 13 years; mean body mass index [BMI] z-score 3.5), the prevalence of VCTE ≥7.4 kPa increased significantly with ALT elevation: 1.9% for normal ALT, 16.4% for mild ALT elevation (≥ upper limit of normal [ULN]: female, 22 IU/L; male, 26 IU/L), 21.3% for moderate ALT elevation (≥2 ULN: female, 44-79 IU/L; male, 52-79 IU/L), and 38.9% for significant ALT elevation (≥80 IU/L) (P < .001). Other noninvasive tests did not perform superiorly in this cohort. VCTE ≥7.4 kPa was positively associated with ALT ≥80 IU/L (odds ratio [OR], 2.91; 95% confidence interval [CI], 1.25-6.74), age (OR, 1.50; 95% CI, 1.27-1.76), male gender (OR, 2.37; 95% CI, 1.04-5.40), BMI z-score (OR, 3.01; 95% CI, 1.62-5.61), and Homeostatic Model Assessment-Insulin Resistance (HOMA-IR) (OR, 1.10; 95% CI, 1.00-1.13). CONCLUSIONS: This study shows that ALT is an effective primary screening step for increased liver stiffness, suggestive of significant fibrosis, in children with obesity or overweight and additional risk factors.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Stroes AR, Draijer L, Chegary M, et al. ALT Is an Effective Screening Tool for Advanced Metabolic Dysfunction-Associated Steatotic Liver Disease in Children With Obesity and Overweight. Clin Gastroenterol Hepatol. 2025. PMID: 40518063. doi:10.1016/j.cgh.2025.05.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。